title: Developmental expression of cellular prion protein and apoptotic molecules in the rat cerebellum: effects of platinum compounds.
abstract: Programmed cell death is regulated by prototypes of a large family of Bcl-2-like proteins such as Bax and Bcl-2. A neuroprotective role for cellular prion protein (PrPc) on programmed cell death has been reported, although the cytosolic accumulation of PrPc correlates with toxicity and death of some neurons by apoptosis. In order to understand the signalling function of PrPc in promoting survival or suppressing cell death, we analyzed the expression and co-localization of PrPc, Bax and Bcl-2 proteins in the developing cerebellum of rats treated at PD10 (postnatal day 10) with the chemotherapeutic drug cisplatin (cisPt) or the new platinum (Pt) compound [Pt(O,O'-acac)(γ-acac)(DMS)] (PtAcacDMS). Differences in the expression of PrPc, Bax and Bcl-2 were found in proliferating cells and immature Purkinje neurons. One day after administration (PD11), cisPt markedly increased the apoptosis of the proliferating cells of the EGL (external granular layer); at the same time, several apoptotic bodies with strong Bax immunoreactivity were noticed. After PtAcacDMS, changes in PrPc and apoptotic proteins, with respect to the controls, were found but Bax immunopositive apoptotic bodies were not detectable, which could mean that apoptotic cell death of proliferating cells is preserved. Co-localization was clearly detected in the Purkinje cell population and may explain better the mechanisms by which PrPc and the apoptotic proteins function, and particularly the role of PrPc. Considering the reactivity of Purkinje neurons to these proteins at PD11 and Pd17, at least PrPc expression increased after cisPt and PtAcacDMS treatments or, if PrPc decreased, balanced itself with Bcl-2. The noteworthiness of this finding is that it emphasizes that most of the post-mitotic Purkinje cells need to be rescued, otherwise they undergo degeneration and are not replaced. Based on the effects of both Pt compounds on Purkinje cell differentiation, it should be emphasized that PrPc, together with the synergistic action of the co-localized anti-apoptotic protein, acts as a neuroprotective protein countering cytotoxicity in the postnatal critical phases of cerebellum development.
authors.affiliation: Dipartimento di Biologia e Biotecnologie "Lazzaro Spallanzani", Università di Pavia, Pavia, Italy. bottone@unipv.it
authors.forename: Maria Grazia
authors.initials: MG
authors.lastname: Bottone
authors.forename: Dal Bo
authors.initials: DB
authors.lastname: Veronica
authors.forename: Valeria Maria
authors.initials: VM
authors.lastname: Piccolini
authors.forename: Giovanni
authors.initials: G
authors.lastname: Bottiroli
authors.forename: Sandra Angelica
authors.initials: SA
authors.lastname: De Pascali
authors.forename: Francesco Paolo
authors.initials: FP
authors.lastname: Fanizzi
authors.forename: Graziella
authors.initials: G
authors.lastname: Bernocchi
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology*; D002531:Cerebellum / Q000187:drug effects / Q000254:growth & development* / Q000378:metabolism*; D018507:Gene Expression Regulation, Developmental; D017671:Platinum Compounds / Q000494:pharmacology*; D018621:PrPC Proteins / Q000096:biosynthesis*; D051381:Rats; D017208:Rats, Wistar; D016896:Treatment Outcome
chemical_list: D017671:Platinum Compounds; D018621:PrPC Proteins